Devices

Indictment on Scheme to Steal Medical Devices for Resale

FDA has announced the unsealing of an indictment charging two former Michigan-based Beaumont Hospital employees and a medical supply distributor with wire fraud based on their scheme to steal medical devices from the hospital and then sell them on the Internet. Charged were: Paul Purdy, 49, of Beavercreek, OH; Valdet Seferovic, 32, of Auburn Hills, MI; and Zafar Khan, 40, of Fenton, MI.

According to the government, from 2003 to 2017, Purdy was employed at Beaumont Hospital and stole medical devices and supplies and resold them via the Internet. “Purdy resigned from the hospital in 2017 and enlisted Seferovic to continue the scheme of stealing medical devices and medical supplies,” the government contends. Purdy and Seferovic primarily stole three types of devices: (1) cystoscopes, a thin tube with a camera which is inserted through the urethra and into the bladder, some of which may have been contaminated as they were stolen from the cleaning and disinfecting room after being used in surgical procedures; (2) ophthalmoscopes, an instrument for inspecting the retina and the other parts of the eye; and (3) otoscopes, an instrument for inspecting the ears.

Additionally, the indictment said Seferovic also agreed to steal and sell medical devices to Khan, the owner of Wholesale Medical & Surgical Suppliers of America. Once Khan acquired the stolen medical devices, he in turn sold them to unsuspecting purchasers via the Internet.

Gupta Raises Concerns About Overton’s Independence, Ideology

FDA commissioner nominee Heidi Overton’s responses on vaccines, contraception and abortion medication during her 9/24 Senate confirmation hearing raise concerns that ideology could influence her decision-making if she takes over the agency, MSNBC senior medical analyst Dr. Vin Gupta said Friday. Gupta was particularly critical of Overton’

Overton Confirmation Remains Uncertain After Senate Hearing

FDA commissioner nominee Heidi Overton emerged from her Senate confirmation hearing Thursday (see earlier story) without resolving questions about whether she has enough Republican support to advance — and with a rapidly narrowing window for confirmation before the midterm elections. The Senate Health, Education, Labor and Pensions Committee hearing provided few

FDA Classifies Boston Scientific Imager II Catheter Recall as Class I

FDA has classified Boston Scientific's recall of its Imager II Angiographic Catheters as Class I because a manufacturing problem could cause catheter tips to degrade and detach, potentially resulting in life-threatening complications. The agency announced the Class I classification 9/25, updating an Early Alert it issued

FDA Approves Gazyva for Childhood-Onset Idiopathic Nephrotic Syndrome

FDA has approved Roche’s Gazyva (obinutuzumab) for reducing the risk of relapse in adults and children aged 2 and older with frequently relapsing or steroid-dependent, childhood-onset idiopathic nephrotic syndrome who are in remission. The expanded approval covers the use of the CD20-directed antibody beyond its existing

Read more

Gupta Raises Concerns About Overton’s Independence, Ideology

Overton Confirmation Remains Uncertain After Senate Hearing

FDA Classifies Boston Scientific Imager II Catheter Recall as Class I

FDA Approves Gazyva for Childhood-Onset Idiopathic Nephrotic Syndrome